Tuberculosis: Symptoms, Transmission, Treatment & Prevention

Mycobacterium tuberculosis is a slow-growing aerobic bacillus whose waxy coat helps it resist routine Gram staining and detergents encountered in macrophages after inhalation into alveoli. Most immunocompetent hosts wall off bacilli inside granulomas—clinically quiet latent TB infection (LTBI). When macrophage restraint fails (HIV/AIDS, diabetes, tumour necrosis-factor inhibitors, extremes of age), organisms replicate to symptomatic active TB disease capable of aerosol transmission from pulmonary or upper-airway sites.

WHO continues to classify TB as among the dominant infectious killers because millions still develop disease yearly when diagnosis, isolation, adherence, or drug supplies slip. Nurses operate at every leak point: spotting the subacute pulmonary syndrome, guarding airborne pathways, supervising complex multidrug timelines, counselling on hepatotoxicity, and escalating culture non-response before resistance amplifies clinic-wide.

Useful scaffolding splits infection versus disease, then localises pathology. Matching language to microbiology avoids ordering the wrong regimen length or prematurely releasing isolation.

↔On a small screen, swipe or scroll sideways to see the full table.

Compared with viral influenza bursts, tuberculosis often evolves over weeks—a low-grade swinging fever, drenching night sweats, creeping unexplained weight loss, appetite collapse, and a cough past three weeks with or without scant blood. Probe travel, incarceration histories, bedside contacts named on public-health forms, homelessness, biomass smoke exposure—all refine pre-test probability quietly.

Hallmark pulmonary constellation

• Persistent productive cough disproportionate to community-acquired pneumonia responsiveness.
• Pleuritic focal pain aligning with peripherally based infiltrates.
• Waxing exertional dyspnea and cachectic fatigue.

Extrapulmonary clues

• Insidious headache and photophobia with lymphocytic CSF—meningeal involvement.
• Progressive back pain with vertebral destruction—Pott disease until proven otherwise in endemic settings.
• Sterile pyuria or epididymal masses—genitourinary TB masquerading as routine urosepsis.

Red flags that stretch beyond routine ward reviews

• Any hemoptysis > blood-streaking or hypoxia refractory to oxygen titration.
• Neurologic change in a patient already on TB therapy—drug toxicity versus expanding abscess.
• Clustered cases on a bay—contact tracing and engineering controls become legal duties.

Airborne physics: infectious droplet nuclei hang suspended in poorly ventilated rooms; talking and singing—not only coughing—liberate organisms. That is why negative-pressure rooms, closed doors, and timed air exchanges matter more than a simple surgical mask on the patient alone.

High-yield risk amplifiers

• Household or prolonged occupational exposure to smear-positive pulmonary cases.
• Immunosuppression including HIV (especially CD4 <200 cells/µL), anti-TNF therapy, post-transplant regimens, prolonged corticosteroids.
• Diabetes and chronic kidney disease blunting granuloma integrity.
• Undernutrition, substance-use disorders, shelter crowding—context that maps social determinants.

ECDC and WHO both emphasise that tuberculosis burden clusters geographically and socially; never interpret a “low local incidence” label as zero risk when personal vulnerability is high.

1. Flag: Cough >3 weeks with constitutional signs, abnormal chest X-ray, or known exposure—activate isolation per policy before waiting for smears.
2. Contain: Move to AIIR, signpost isolation precautions on doors, limit transport, apply PPE donning and doffing sequences without shortcuts.
3. Sample: Expectorate deep sputum culture sets (early-morning preferred) with chain-of-custody labelling; coach specimen collection technique.
4. Amplify: Nucleic-acid amplification plus liquid culture guide susceptibility—document collection times for audit.
5. Treat: Start multidrug empiric therapy when clinical probability is high and local resistance patterns support the chosen backbone—never monotherapy.
6. Observe: Trend vital signs, weights, LFTs, vision (ethambutol), peripheral sensation, and mental status on a calendar.
7. Release: Step-down isolation only when microbiologic and clinical criteria plus infection-prevention sign-off align.

Diagnosis couples epidemiology, imaging, immune-based infection tests, and microbiology. Rapid molecular assays now front-load drug-susceptibility signals—supporting earlier tailored regimens per WHO rapid-diagnostic recommendations.

Immunologic detection of infection

• IGRA (TB blood test): preferred in many BCG-vaccinated individuals because live BCG less often confounds than tuberculin protein derivatives.
• Tuberculin skin test: still used where IGRA availability lags; measure induration at 48–72 h and interpret against risk.

Imaging & procedural escalation

• Chest radiography or CT when respiratory symptoms or positive infection tests without prior imaging.
• Bronchoscopy-guided washings when expectorated sputum repeatedly fails and clinical suspicion remains high.

Microscopy & culture expectations

↔On a small screen, swipe or scroll sideways to see the full table.

TB shares B-symptoms with lymphoproliferative disorders and chronic pulmonary infections; anchor differentials on tempo, radiology, and microbiology rather than intuition alone.

↔On a small screen, swipe or scroll sideways to see the full table.

Drug-susceptible pulmonary TB classically uses a two-month intensive phase with four agents—rifampin, isoniazid, pyrazinamide, and ethambutol—followed by continuation with rifampin plus isoniazid for at least four additional months when cultures convert and toxicity allows. Extrapulmonary sites (CNS, bone) often extend total duration per specialist advice.

Latent infection treatment (when active disease excluded)

Shorter rifapentine–isoniazid weekly regimens or four-month rifampin monotherapy appear in many national algorithms when hepatitis risk and drug interactions are acceptable—document baseline LFTs and symptom diary education.

Multidrug-resistant TB (awareness layer)

Resistance to rifampin and isoniazid demands prolonged oral/injectable combinations with audiology, psychiatry, and pharmacy co-management; nurses track QT intervals, electrolytes, and mental health on long regimens.

Special populations

• HIV coinfection: earlier ART integration when safe from inflammatory flare; often requires overlapping toxicology surveillance.
• Pregnancy: avoid pyrazinamide in some regions; specialist obstetric ID input essential—never leave TB untreated.
• Liver disease: weigh hepatotoxic agents against alternatives; intensify ALT/AST monitoring frequency.

• Pair DOT or video-observed therapy with relational coaching—adherence failure seeds resistance faster than any ward delay.
• Run weekly (or per protocol) safety labs during intensive phase; halt ethambutol promptly if visual symptoms arise.
• Reconcile interacting medicines (rifampin induces CYP enzymes—oral contraceptives, warfarin, some antiretrovirals).
• Chart temperature curves and sputum volume—subtle improvement matters for morale and discharge planning.
• Inform occupational health proactively after significant unprotected aerosol exposures; arrange baseline and follow-up testing.

• Massive hemoptysis airway compromise requiring interventional bronchial tamponade or IR.
• Empyema, bronchopleural fistula, spontaneous pneumothorax.
• Pott paraplegia, TB pericarditis with tamponade physiology.
• Drug-induced hepatitis or peripheral neuropathy from isoniazid without concurrent pyridoxine provision.
• Amplified resistance due to covert treatment interruption—communicate plainly with patients about consequences.

Preventive chemotherapy for LTBI, BCG vaccination in high-incidence infancy programmes per national policy, airborne engineering controls (UVGI, ACH targets), respiratory protection programmes with annual fit-testing, and rapid outpatient initiation of contagious-case therapy collectively bend incidence curves—as summarised jointly by CDC, WHO, and NICE service organisation guidance.

Drug-susceptible TB treated with adherence typically achieves culture conversion early in therapy; lingering cough or radiographic shadows can persist innocuously months. Conversely, socioeconomic instability, substance use, homelessness, mental illness correlate with relapse—wraparound services shorten readmissions.

Before culture confirmation

• Airborne zoning, signage, supervised visitor education, aerosol-producing procedure checks.
• Smoke cessation hooks—tobacco synergy worsens cavities and coughing intensity.

During multidrug therapy

• Daily adherence verification, hepatitis symptom screens, reddish-orange discoloration counselling for rifampin excretions.
• Dietitian referral when BMI trends downward despite therapy.

Evaluation

• Teach symptom diary for neuropathy rash jaundice; loop pharmacist when pill burden overwhelms cognition.

Fear-based messaging erodes adherence—pair clinical honesty with logistical help (travel vouchers for DOT, multilingual leaflets). Respiratory assessment granularity (trend RR, paradoxical abdominal breathing, whispered speech fatigue) communicates deterioration earlier than NEWS alone in hallway updates.

• SpO₂, RR, workload of breathing twice per shift minimum when hypoxic.
• Mental status snapshots when hepatic impairment coexists—confusion precedes catastrophic LFT spikes.
• Weekly weight trending until plateau or gain resumes.
• Drain output colour if thoracotomy or pigtail present—sudden blood surge triggers rapid response rehearsal.

Maintain airborne precautions during transport communications; preload blood bank only when massive hemoptysis pathways demand.

Rising NEWS without clear focal infection, recrudescent fever after sterile cultures, paradoxical widening infiltrates shortly after ART—each scenario deserves senior ID review the same nursing shift rather than “wait for rounds.” Objective metrics (rising WBC anew, widening QTc after MDR meds) belong in escalation emails with timestamps matching monitor strips.

Nursing-priority lens (NCSBN Clinical Judgment Measurement Model): recognise cues → analyse cues → prioritise hypotheses → generate solutions → take safe action → evaluate outcomes. These NCLEX-style clinical judgment practice items rotate Priority FIRST, SATA, deterioration cues, airborne triage, ordered isolation sequences, infection-control matrix drills, plus cloze fill-ins on latent therapy and microscopy thresholds—emphasising the Clinical Judgment Measurement Model layers for protection, analysis, action, and evaluation.